Latest News

The FDA has been questioned on clinical drug data coming from China

New report accuses the EMA of excessive secrecy. Prescrire has stated that lack of transparency compromises the rights of EU citizens to access data

In human clinical trials, the product label is the source of that power – it's the voice of the product and it needs to speak clearly throughout a highly complex process

Risk-based quality management (RBQM) is nothing new – it's been around in some form or another for a long time – but over that time

We live in a big world, that's getting smaller every day in many ways

Clinical Research is all about going forwards. Even when things need to go back

New Zealand gives clearance for base editing therapy trial in humans

A new era of smart therapeutics with first-ever computationally designed antibody